TBC
ISEE

Three Bays Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Three Bays Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-846,007
Closed -$39M – 30
2016
Q3 		$39M Buy
846,007
+495,413
+141% +$27.9M 2.59% 13
2016
Q2 		$17.9M Buy
+350,594
New +$17.4M 0.93% 15

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Three Bays Capital's ISEE Position: Q4 2016 in Review

Three Bays Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 846,007 shares — an estimated $39M sold.

Three Bays Capital first reported a position in ISEE in Q2 2016 and held it in 2 quarters. The position peaked at $39M in Q3 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Three Bays Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Three Bays Capital sold 846,007 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $39M.
  • Three Bays Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Three Bays Capital's IVERIC bio, Inc. Common Stock position peaked at $39M in Q3 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Three Bays Capital's 13F filing for Q4 2016, filed 14 Feb 2017.